Atlas Trials

Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects

Clinical trial NCT01195688 · COMPLETED

Trial details

NCT number
NCT01195688
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2010-09-01
Primary completion
2010-12-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.